ArticleThe British journal of dermatology2024

Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.

Réda Chebani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.